photo of Dr Nicole Messina

Dr Nicole Messina

Dr Nicole Messina

Details

Role Team Leader / Senior Research Officer

Contact

Available for student supervision
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the Peter MacCallum Cancer Centre investigating crosstalk in cytokine signalling pathways and the role of interferon signalling pathways in tumour immunosurveillance. Her previous research has also included investigating the role of cytokine response pathways in regulatory T cell development and function. Dr Messina co-supervises four PhD students, holds an Honorary Research Fellow appointment with the University of Melbourne and is a member of the Melbourne Children's Graduate Research Committee and MCRI animal ethics committee.
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the...
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the Peter MacCallum Cancer Centre investigating crosstalk in cytokine signalling pathways and the role of interferon signalling pathways in tumour immunosurveillance. Her previous research has also included investigating the role of cytokine response pathways in regulatory T cell development and function. Dr Messina co-supervises four PhD students, holds an Honorary Research Fellow appointment with the University of Melbourne and is a member of the Melbourne Children's Graduate Research Committee and MCRI animal ethics committee.

Top Publications

  • Pittet, LF, Noble, CCA, Messina, NL, Curtis, N. Using BCG vaccination to protect against COVID-19: when reality fails to meet expectation. Nature Reviews Immunology 24(2) : 83 -84 2024
    view publication
  • Chen, KYH, Messina, N, Germano, S, Bonnici, R, Freyne, B, Cheung, M, Goldsmith, G, Kollmann, TR, Levin, M, Burgner, D, et al. Innate immune responses following Kawasaki disease and toxic shock syndrome. PLOS ONE 13(2) : e0191830 2024
    view publication
  • Gough, DJ, Messina, NL, Hii, L, Gould, JA, Sabapathy, K, Robertson, APS, Trapani, JA, Levy, DE, Hertzog, PJ, Clarke, CJP, et al. Functional Crosstalk between Type I and II Interferon through the Regulated Expression of STAT1. PLOS Biology 8(4) : e1000361 2024
    view publication
  • Zimmermann, P, Ritz, N, Perrett, KP, Messina, NL, van der Klis, FRM, Curtis, N. Correlation of Vaccine Responses. Frontiers in Immunology 12: 646677 2024
    view publication
  • Villanueva, P, Wadia, U, Crawford, N, Messina, NL, Kollmann, TR, Lucas, M, Manning, L, Richmond, P, Pittet, LF, Curtis, N. Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy. npj Vaccines 7(1) : 6 2024
    view publication

Page 1 of 12

Career information